Hikal Limited (NSE:HIKAL)
160.96
+1.00 (0.63%)
Apr 2, 2026, 3:29 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 19.81 billion as of April 2, 2026. Its market cap has decreased by -58.90% in one year.
Market Cap
19.81B
Enterprise Value
26.45B
Revenue
17.46B
Ranking
n/a
PE Ratio
n/a
Stock Price
160.96
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 19.81B, an increase of 1,359.94%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 19.81B | -29.18% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 40.28B |
| Sun Pharma Advanced Research Company | 39.05B |
| RPG Life Sciences | 31.05B |
| Orchid Pharma | 26.34B |
| Solara Active Pharma Sciences | 22.12B |
| Indoco Remedies | 17.27B |
| Windlas Biotech | 16.18B |
| Beta Drugs | 12.82B |